Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18698826rdf:typepubmed:Citationlld:pubmed
pubmed-article:18698826lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:18698826lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:18698826lifeskim:mentionsumls-concept:C1515568lld:lifeskim
pubmed-article:18698826lifeskim:mentionsumls-concept:C2606016lld:lifeskim
pubmed-article:18698826pubmed:issue18lld:pubmed
pubmed-article:18698826pubmed:dateCreated2008-9-15lld:pubmed
pubmed-article:18698826pubmed:abstractTextAn efficient enantioselective synthesis of (+)-isofregenedol was achieved in 13 steps from commercially available cyclohexene oxide without the use of protecting groups. The tetrahydronaphthalenic core of isofregenedol was obtained via a gold(I)-catalyzed benzannulation recently developed in our laboratory.lld:pubmed
pubmed-article:18698826pubmed:languageenglld:pubmed
pubmed-article:18698826pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18698826pubmed:citationSubsetIMlld:pubmed
pubmed-article:18698826pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18698826pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18698826pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18698826pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18698826pubmed:statusMEDLINElld:pubmed
pubmed-article:18698826pubmed:monthSeplld:pubmed
pubmed-article:18698826pubmed:issn1520-6904lld:pubmed
pubmed-article:18698826pubmed:authorpubmed-author:BarriaultLoui...lld:pubmed
pubmed-article:18698826pubmed:authorpubmed-author:RiouMaximeMlld:pubmed
pubmed-article:18698826pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18698826pubmed:day19lld:pubmed
pubmed-article:18698826pubmed:volume73lld:pubmed
pubmed-article:18698826pubmed:ownerNLMlld:pubmed
pubmed-article:18698826pubmed:authorsCompleteYlld:pubmed
pubmed-article:18698826pubmed:pagination7436-9lld:pubmed
pubmed-article:18698826pubmed:meshHeadingpubmed-meshheading:18698826...lld:pubmed
pubmed-article:18698826pubmed:meshHeadingpubmed-meshheading:18698826...lld:pubmed
pubmed-article:18698826pubmed:meshHeadingpubmed-meshheading:18698826...lld:pubmed
pubmed-article:18698826pubmed:meshHeadingpubmed-meshheading:18698826...lld:pubmed
pubmed-article:18698826pubmed:meshHeadingpubmed-meshheading:18698826...lld:pubmed
pubmed-article:18698826pubmed:meshHeadingpubmed-meshheading:18698826...lld:pubmed
pubmed-article:18698826pubmed:year2008lld:pubmed
pubmed-article:18698826pubmed:articleTitleDe novo synthesis of (+)-isofregenedol.lld:pubmed
pubmed-article:18698826pubmed:affiliationDepartment of Chemistry, 10 Marie Curie, University of Ottawa, Ottawa, Canada K1N 6N5.lld:pubmed
pubmed-article:18698826pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18698826pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed